Balance Sheet
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Gsk (GLAXF) Equity Average (2016 - 2025)

Gsk has reported Equity Average over the past 10 years, most recently at $19.7 billion for Q4 2025.

  • Quarterly results put Equity Average at $19.7 billion for Q4 2025, up 15.3% from a year ago — trailing twelve months through Dec 2025 was $19.7 billion (up 15.3% YoY), and the annual figure for FY2025 was $19.7 billion, up 15.3%.
  • Equity Average for Q4 2025 was $19.7 billion at Gsk, up from $17.1 billion in the prior quarter.
  • Over the last five years, Equity Average for GLAXF hit a ceiling of $19.8 billion in Q4 2021 and a floor of $14.5 billion in Q4 2023.
  • Median Equity Average over the past 5 years was $17.1 billion (2024), compared with a mean of $17.5 billion.
  • Biggest five-year swings in Equity Average: fell 17.27% in 2022 and later grew 17.64% in 2024.
  • Gsk's Equity Average stood at $19.8 billion in 2021, then fell by 17.27% to $16.4 billion in 2022, then decreased by 11.39% to $14.5 billion in 2023, then rose by 17.64% to $17.1 billion in 2024, then rose by 15.3% to $19.7 billion in 2025.
  • The last three reported values for Equity Average were $19.7 billion (Q4 2025), $17.1 billion (Q4 2024), and $14.5 billion (Q4 2023) per Business Quant data.